theMednetRegister
  • Community
    • Overview
    • Experts
    • Editors
    • Fellows
    • Code of conduct
    • AI Guidelines for Physicians
  • Company
    • About Us
    • FAQs
    • Privacy Policy
    • Terms of Use
    • Careers
    • Programs
  • News
    • News Releases
    • Press Coverage
    • Publications
    • Blog
  • Contact Us
  • Sign in

COVID-19

General Primary Care   

Questions discussed in this category


What pharmacologic and non-pharmacologic strategies have you found helpful in managing brain fog following COVID-19 infection?
1 Answer available

What is your preferred first-line treatment for chronic fatigue in patients with long COVID-19?
9 Answers available
2656313004


Papers discussed in this category


Medical sciences (Basel, Switzerland), 2018-09-21
Low-Dose Naltrexone (LDN)-Review of Therapeutic Utilization.

The Journal of clinical investigation, 2021 Dec 15
The intersection of COVID-19 and autoimmunity.

Molecular systems biology, 2023 Mar 15
A methylation clock model of mild SARS-CoV-2 infection provides insight into immune dysregulation.

BMJ open, 2024 May 13
Low-dose naltrexone for post-COVID fatigue syndrome: a study protocol for a double-blind, randomised trial in British Columbia.

PM & R : the journal of injury, function, and rehabilitation, 2022 Jan 12
Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of cognitive symptoms in patients with post-acute sequelae of SARS-CoV-2 infection (PASC).

Related Topics in COVID-19

  • Breast Cancer
  • Head and Neck Cancers
  • Hematologic Malignancies
  • Radiation Oncology
  • Gynecologic Oncology
  • Gastrointestinal Cancers
  • Genitourinary Cancers
  • Melanoma/Skin Cancer
  • Non-malignant Disease
  • Pediatric Hematology/Oncology

Copyright © 2025 theMednet
All Rights Reserved.